Ionis Pharmaceuticals (IONS) EPS (Weighted Average and Diluted) (2009 - 2026)
Ionis Pharmaceuticals (IONS) recorded quarterly EPS (Weighted Average and Diluted) of -$0.56 in Q1 2026, up 60.28% quarter-over-quarter from -$1.41 in Q4 2025, and up 39.78% on a YoY basis from -$0.4 in Q1 2025.
Ionis Pharmaceuticals (IONS) EPS (Weighted Average and Diluted) (2009 - 2026) Analysis & Trends
Ionis Pharmaceuticals' EPS (Weighted Average and Diluted) history runs 18 years deep, the most recent figure standing at -$0.56 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) rose 39.78% year-over-year to -$0.56; the TTM figure through Mar 2026 stood at -$2.07 (up 30.77% YoY), while the FY2025 annual figure was -$2.38, up 21.71% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.56 for Q1 2026 at Ionis Pharmaceuticals, up from -$1.41 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.7 in Q2 2025 to a low of -$1.41 in Q4 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.62 across 5 years, with a median of -$0.66 in 2024.
- The sharpest annual moves came in 2024 and 2025: EPS (Weighted Average and Diluted) tumbled 1000.0% in 2024, then soared 255.56% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.37 in 2022, then soared by 83.78% to -$0.06 in 2023, then sank by 1000.0% to -$0.66 in 2024, then sank by 113.64% to -$1.41 in 2025, then surged by 60.28% to -$0.56 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.56 (Q1 2026), -$1.41 (Q4 2025), and -$0.8 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Ionis Pharmaceuticals | 12.23 Bn | 10.31 Bn | 243.11 Mn | -0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.56 |
| Dec 31, 2025 | -1.41 |
| Sep 30, 2025 | -0.80 |
| Jun 30, 2025 | 0.70 |
| Mar 31, 2025 | -0.93 |
| Dec 31, 2024 | -0.66 |
| Sep 30, 2024 | -0.95 |
| Jun 30, 2024 | -0.45 |
| Mar 31, 2024 | -0.98 |
| Dec 31, 2023 | -0.06 |
| Sep 30, 2023 | -1.03 |
| Jun 30, 2023 | -0.60 |
| Mar 31, 2023 | -0.87 |
| Dec 31, 2022 | -0.37 |
| Sep 30, 2022 | -0.33 |
| Jun 30, 2022 | -0.74 |
| Mar 31, 2022 | -0.46 |
| Dec 31, 2021 | 1.41 |
| Sep 30, 2021 | -0.58 |
| Jun 30, 2021 | -0.57 |